Status: In Minnesota, all individuals with a legal prescription may possess and use medical marijuana. State licensed businesses may grow, process, transport, and dispense medical marijuana.
|CBD Program||Medical Program||Recreational Program||Are Applications Open?|
Number of Minnesota Licenses Available
Minnesota Medical Marijuana Business Guidelines
- The bill allows for two manufacturing facilities and eight dispensaries statewide
- Each of the two registered manufacturers will establish and operate four distribution facilities around the state, for a total of eight.
- In July of 2015, the first dispensary in the state opened its doors to patients.
REQUIRED MINNESOTA MARIJUANA BUSINESS PLANS FOR APPLICATION:
- Business & Operations Plan Template
- Cultivation Plan Template
- Manufacturing/Processing Plan Template
- Environmental Plan Template
- Financial Plan Template
- Fire Safety Plan Template
- Inventory Control Plan Template
- Patient Education Plan Template
- Patient Recordkeeping Plan Template
- Product Safety Plan Template
- Security Plan Template
- Staffing Plan Template
- Suitability of Proposed Plan Template
- Transportation Plan Template
RECOMMENDED MINNESOTA MARIJUANA BUSINESS PLANS FOR APPLICATION:
The History of Minnesota Marijuana
In May of 2014, Minnesota passed a medical marijuana bill, known as the Medical Cannabis Therapeutic Use Act, allowing for the possession and use of medical marijuana for qualifying patients in the state. The bill allows for two manufacturing facilities and eight dispensaries statewide. Each of the two registered manufacturers will establish and operate four distribution facilities around the state, for a total of eight. In July of 2015, the first dispensary in the state opened its doors to patients.
Qualifying Medical Conditions: Amyotrophic Lateral Sclerosis, Cancer/cachexia, Glaucoma, HIV/AIDS, Seizures, Severe and persistent muscle spasms, Terminal illness, Tourette’s Syndrome.
A medical marijuana review panel held a public meeting on October 24, 2018 to discuss petitions to add opioid use disorders, panic disorder, Alzheimer’s, and psoriasis as qualifying conditions for medical marijuana treatment. The panel will make its official recommendations to the Department of Health Commissioner by November 1, 2018. The Commissioner must then make a decision by December 1, 2018.